Brian Taylor Slingsby, Director at Mineralys Therapeutics, Inc., holds 7.81M shares in Mineralys Therapeutics, Inc. (Ticker: MLYS). Most recently, Brian Taylor Slingsby Sold 104,320 shares of Mineralys Therapeutics, Inc. on Sep 24, 2026 for an estimated value of $3.00M.
What is the percentage of profitable transactions made by Brian Taylor Slingsby?
The percentage of profitable transactions made by Brian Taylor Slingsby is 80%.
What is the average return per transaction made by Brian Taylor Slingsby?
The average return per transaction made by Brian Taylor Slingsby is 48.50%.
What stocks does Brian Taylor Slingsby hold?
Brian Taylor Slingsby holds: MLYS stocks.
What was Brian Taylor Slingsby’s latest transaction?
Brian Taylor Slingsby latest transaction was an Informative Sell of $3.00M.
What was Brian Taylor Slingsby's most profitable transaction?
Brian Taylor Slingsby’s most profitable transaction was an Informative Buy of MLYS stock on April 25, 2025. The return on the trade was 213.80%.
What is Brian Taylor Slingsby's role in Mineralys Therapeutics, Inc.?
Brian Taylor Slingsby's role in Mineralys Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.